BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16305725)

  • 21. Collagenous colitis: histopathology and clinical course.
    Goff JS; Barnett JL; Pelke T; Appelman HD
    Am J Gastroenterol; 1997 Jan; 92(1):57-60. PubMed ID: 8995938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anorectal function in patients with collagenous colitis in active and clinically quiescent phase, in comparison with healthy controls.
    Walter SA; Münch A; Ost A; Ström M
    Neurogastroenterol Motil; 2010 May; 22(5):534-8, e118. PubMed ID: 20156310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. After budesonide, what next for collagenous colitis?
    Pardi DS
    Gut; 2009 Jan; 58(1):3-4. PubMed ID: 19091826
    [No Abstract]   [Full Text] [Related]  

  • 24. Microscopic colitis: an update.
    Tangri V; Chande N
    J Clin Gastroenterol; 2009 Apr; 43(4):293-6. PubMed ID: 19169149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to remission with budesonide in collagenous colitis.
    Miehlke S; Madisch A; Bethke B; Stolte M
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1507-8; author reply 1508. PubMed ID: 15948819
    [No Abstract]   [Full Text] [Related]  

  • 26. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial.
    Miehlke S; Heymer P; Bethke B; Bästlein E; Meier E; Bartram HP; Wilhelms G; Lehn N; Dorta G; DeLarive J; Tromm A; Bayerdörffer E; Stolte M
    Gastroenterology; 2002 Oct; 123(4):978-84. PubMed ID: 12360457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis.
    Bonderup OK; Hansen JB; Birket-Smith L; Vestergaard V; Teglbjaerg PS; Fallingborg J
    Gut; 2003 Feb; 52(2):248-51. PubMed ID: 12524408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adalimumab in budesonide and methotrexate refractory collagenous colitis.
    Münch A; Ignatova S; Ström M
    Scand J Gastroenterol; 2012 Jan; 47(1):59-63. PubMed ID: 22149977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for symptom relapse in collagenous colitis after withdrawal of short-term budesonide therapy.
    Miehlke S; Hansen JB; Madisch A; Schwarz F; Kuhlisch E; Morgner A; Teglbjaerg PS; Vieth M; Aust D; Bonderup OK
    Inflamm Bowel Dis; 2013 Dec; 19(13):2763-7. PubMed ID: 24216688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonic mucosal tears in collagenous colitis.
    Wickbom A; Lindqvist M; Bohr J; Ung KA; Bergman J; Eriksson S; Tysk C
    Scand J Gastroenterol; 2006 Jun; 41(6):726-9. PubMed ID: 16716973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis.
    Bajor A; Kilander A; Gälman C; Rudling M; Ung KA
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1643-9. PubMed ID: 17094773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis.
    Lindgren S; Löfberg R; Bergholm L; Hellblom M; Carling L; Ung KA; Schiöler R; Unge P; Wallin C; Ström M; Persson T; Suhr OB
    Scand J Gastroenterol; 2002 Jun; 37(6):705-10. PubMed ID: 12126250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.
    de Jong DJ; Bac DJ; Tan G; de Boer SY; Grabowsky IL; Jansen JB; Greinwald R; Naber TH
    Neth J Med; 2007 Oct; 65(9):339-45. PubMed ID: 17954953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagenous colitis: a retrospective survey of patients with chronic diarrhea.
    Hatemi AI; Senateş E; Dobrucali A; Göksel S
    Hepatogastroenterology; 2011; 58(112):1963-7. PubMed ID: 22024068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis.
    Kirwan JR; Hällgren R; Mielants H; Wollheim F; Bjorck E; Persson T; Book C; Bowman S; Byron M; Cox N; Field M; Kanerud L; Leirisalo-Repo M; Malaise M; Mohammad A; Palmer R; Petersson IF; Ringertz B; Sheldon P; Simonsson M; Snowden N; Van den Bosch F
    Ann Rheum Dis; 2004 Jun; 63(6):688-95. PubMed ID: 15140776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventions for treating collagenous colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003575. PubMed ID: 18425892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral budesonide in the treatment of chronic refractory pouchitis.
    Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
    Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evolution and treatment response in microscopic colitis].
    Miquel Plaza J; López SanRomán A; del Pozo D; Peña E; Bermejo F; Baleriola I; Moreira V; García Plaza A
    Gastroenterol Hepatol; 2001 Nov; 24(9):433-9. PubMed ID: 11722819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microscopic colitis: an unfamiliar but treatable disease.
    van der Wouden EJ; Karrenbeld A; Kleibeuker JH; Dijkstra G
    Neth J Med; 2009 Feb; 67(2):41-5. PubMed ID: 19299845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study.
    Tursi A; Giorgetti GM; Brandimarte G; Elisei W; Aiello F
    Med Sci Monit; 2006 Jun; 12(6):PI29-32. PubMed ID: 16733496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.